Yao, W. et al. 2022. Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Feb. 2022), e2022025. DOI:https://doi.org/10.4084/MJHID.2022.025.